We are excited to announce our $9.5M seed round! The investment is led by Northzone, with participation of angel operators from OpenAI & Google DeepMind, the founder of Capio Sverige, and healthcare VC Amino Collective. We are on a mission to revolutionize European healthcare through our clinician copilot. Our copilot enables clinicians to focus on care, instead of on administrative tasks. Currently we are actively hiring across all roles, find more info at: https://lnkd.in/d8V_K_kr. Read more about our journey in the articles linked in the comments by Sifted, Business Insider, and Dagens industri.
Amino Collective
Wagniskapital- und Private-Equity-Auftraggeber
Berlin, Berlin 1.909 Follower:innen
– FREE – AND – RADICAL –
Info
Amino Collective’s primary investment focus lies within the realms of health and bio. We help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. We invest in early-stage ventures that have a European focus and the ambition to scale globally. We invest in early-stage ventures that have a European focus and the ambition to scale globally.
- Website
-
https://www.aminocollective.com/
Externer Link zu Amino Collective
- Branche
- Wagniskapital- und Private-Equity-Auftraggeber
- Größe
- 2–10 Beschäftigte
- Hauptsitz
- Berlin, Berlin
- Art
- Privatunternehmen
- Gegründet
- 2020
- Spezialgebiete
- Biology, Bio-Tech, Health-Tech, Science, Digital Health, Life Science und Synthetic Biology
Orte
-
Primär
Berlin, Berlin, DE
Beschäftigte von Amino Collective
Updates
-
Amino Collective hat dies direkt geteilt
AI is accelerating innovation in health and bio. Excited to be co-hosting this for Amino Collective, join us in Munich if you are (curious about) building a company in this space!
🌟 Unlocking the Future of AI in Biotech: Join Nucleate Germany for an Exciting Evening! We are thrilled to partner with Amino Collective for an engaging event focused on the revolutionary impact of AI in Biotech. AI is rapidly transforming the biotech landscape, driving innovations in drug discovery, personalized medicine, and advanced diagnostics. This evening promises to shed light on how #AI is accelerating research, reducing costs, and opening new frontiers in #healthcare. 🗓️ Date: June 20th 📍 Location: TranslaTUM, Munich ⏰ Time: 6:30 PM Event Highlights: Speakers: Martin Patz, fungitional.bio: Explore how AI is being utilized to develop #functional foods and innovative biotech solutions. Sunny Sun & Alex Wolf, Lamin Labs: Gain insights into how AI and machine learning are transforming lab automation and accelerating scientific research. Engage with our speakers in the Q&A session on the latest advancements in AI and Biotech. This is your chance to ask burning questions and delve deeper into the future of the industry. Connect with industry leaders, innovators, and peers. Share ideas, discuss collaborations, and expand your professional network in a relaxed atmosphere with provided snacks and drinks. Whether you're a biotech enthusiast, an AI #researcher, or a #startup founder, this event is an excellent opportunity to stay ahead of the curve, gain valuable insights, and be part of the conversation shaping the #future of #biotech. We look forward to welcoming you to this inspiring evening! Sign up here: https://lu.ma/uf91fqxe
-
-
Amino Collective hat dies direkt geteilt
We’re excited to announce that ExpressionEdits has secured $13M in seed funding co-led by Octopus Ventures and redalpine, with participation from BlueYard Capital, Wilbe Capital, Acequia Capital, Amino Collective, and Hawktail. Our team is on a mission to optimize protein expression using AI and our proprietary intronization technology. Thank you to our investors and partners for believing in our vision. https://lnkd.in/emv5mzFn #biotech #funding #lifesciences
-
Amino Collective hat dies direkt geteilt
🌟 New blog! 🌟 Following up on our recent blog "Reflections on Establishing a Healthcare-Focused Fund of Funds," we are thrilled to present the second part of our series: "Strategic Healthcare Insights Shaping Our Investment Approach." From Shira Eting, Principal, at Vintage. 🩺 This segment dives into key healthcare sub-sectors: 🔬 Life Sciences 💻 Digital Health 🧬 Tech-Bio + offers an in-depth look at how these areas shape our investment strategies and decisions. We invite you to dive into the second part of the article, gain insights into our nuanced investment approach, and see how we leverage these insights for better outcomes. Special shout out to 7wireVentures, Virtue General Catalyst, a16z Bio + Health, Versant Ventures, Pontifax Venture Capital, KdT Ventures, and Amino Collective 🎇 🙌 And if you missed it, check out the first part of the blog here: https://lnkd.in/dRaBUYXQ Enjoy! 🚀
Part 2: Strategic Healthcare Insights Shaping Our Investment Approach
Vintage Investment Partners auf LinkedIn
-
Well said by the always eloquent Stef van Grieken: “However, from a talent perspective I think Europe is underappreciated,” van Grieken continued. “For example, here in Zurich, you have all major big tech companies (Apple, Google, Facebook) represented with thousands of engineers. You have a fantastic talent pool coming out of ETH and EPFL, which are some of the best universities for computer science and molecular biology in the world. And competition for talent is definitely less intense than in the Bay Area. Finally, many of the largest pharma and biotech companies in the world are located in Europe, so we are close to our customers. I definitely think the European ecosystem is developing rapidly.” Amino Collective 💜 Cradle https://lnkd.in/eRr5MNpZ
Cradle's AI-powered protein programming platform levels up with $24M in new funding | TechCrunch
https://techcrunch.com